SCHEMBL526140

SCHEMBL526140

FC(F)(F)c1cc[c]c(Br)c1-c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 1/20 0.37
KIF11 P52732 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.33
ESR1 P03372 1/20 0.33
POLB P06746 1/20 0.32
BACE1 P56817 1/20 0.32
ALDH1A1 P00352 2/20 0.31
TSHR P16473 1/20 0.31
HSD11B1 P28845 1/20 0.31
NR1H2 P55055 1/20 0.31
NR1H3 Q13133 1/20 0.31
S1PR1 P21453 1/20 0.31
ACHE P22303 2/20 0.30
ENPP1 P22413 1/20 0.30
MAPK1 P28482 1/20 0.30
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2394087 0.80 FABP4 (0.38) FABP4KIF11L3MBTL1ESR1POLB
SCHEMBL6672493 0.80 FABP4 (0.38) FABP4KIF11L3MBTL1ESR1POLB
SCHEMBL4443952 0.75 FABP4 (0.35) FABP4KIF11L3MBTL1ESR1
SCHEMBL1801180 0.72 TAS2R14 (0.30)
SCHEMBL8691275 0.72 AR (0.35) FABP4KIF11ESR1POLBALDH1A1
SCHEMBL2597832 0.72 FABP4 (0.53) FABP4KIF11L3MBTL1ESR1POLB
SCHEMBL7105084 0.69 KIF11 (0.36) KIF11ALDH1A1TSHRHSD11B1S1PR1
SCHEMBL28222652 0.69 KIF11 (0.54) FABP4KIF11L3MBTL1ESR1ALDH1A1
SCHEMBL1068717 0.69 CA2 (0.34) L3MBTL1POLBALDH1A1HSD11B1LMNA
SCHEMBL10768905 0.68 KIF11 (0.35) KIF11ALDH1A1TSHRHSD11B1NR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598483-A1 AMPK-ACTIVATING HETEROCYCLIC COMPOUNDS AND METHODS FOR USING THE SAME Rigel Pharmaceuticals, Inc. (US) 2013-06-05 EP disclosed
WO-2012016217-A1 AMPK-ACTIVATING HETEROCYCLIC COMPOUNDS AND METHODS FOR USING THE SAME RIGEL PHARMACEUTICALS, INC. (US) 2012-02-02 WO disclosed